Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q4 | $146.9M | -- | -- | $0.13 | -- |
| 11/21/2025 | Q3 | $156.4M | $159.2M | $1.11 | $0.20 | $0.91 |
| 08/05/2025 | Q2 | $149.8M | $143.9M | -$1.15 | $0.14 | -$1.29 |
| 05/07/2025 | Q1 | $140.8M | $143.4M | -$0.88 | $0.07 | -$0.96 |
| 02/05/2025 | Q4 | $146M | $147.5M | -$0.29 | $0.06 | -$0.35 |
| 11/12/2024 | Q3 | $169.8M | $170.1M | -$0.10 | $0.11 | -$0.22 |
| 08/06/2024 | Q2 | $168.5M | $144.3M | -$0.12 | $0.07 | -$0.19 |
| 05/08/2024 | Q1 | $159.9M | $136.4M | -$2.47 | $0.02 | -$2.49 |
| 02/07/2024 | Q4 | $151.2M | $141.7M | -$0.28 | -$0.03 | -$0.24 |
| 11/13/2023 | Q3 | $163.9M | $172.4M | $0.06 | $0.02 | $0.04 |
| 08/08/2023 | Q2 | -- | $165.9M | -$0.04 | -- | -- |
| 05/09/2023 | Q1 | -- | $148.4M | -$0.07 | -- | -- |
| 02/08/2023 | Q4 | -- | $178.4M | -$0.15 | -- | -- |
| 11/14/2022 | Q3 | -- | $137.6M | -$0.30 | -- | -- |
| 08/09/2022 | Q2 | -- | $132.7M | -$0.11 | -- | -- |
| 05/09/2022 | Q1 | -- | $145.5M | -$5.89 | -- | -- |
| 02/08/2022 | Q4 | -- | $139.7M | $0.58 | -- | -- |
| 11/10/2021 | Q3 | -- | $136.9M | $0.29 | -- | -- |
| 06/30/2021 | Q2 | -- | $129.1M | $0.53 | -- | -- |
| 03/31/2021 | Q1 | -- | $129.5M | $0.32 | -- | -- |
| 12/31/2020 | Q4 | -- | $118.1M | $0.35 | -- | -- |
| 09/30/2020 | Q3 | -- | $108.2M | $0.39 | -- | -- |
| 06/30/2020 | Q2 | -- | $220.4M | $0.19 | -- | -- |
| 03/31/2020 | Q1 | -- | $220.2M | $0.12 | -- | -- |
| 12/31/2019 | Q4 | -- | $210.5M | $0.18 | -- | -- |
| 09/30/2019 | Q3 | -- | $200.2M | $0.06 | -- | -- |
| 06/30/2019 | Q2 | -- | $203.9M | $0.10 | -- | -- |
| 03/31/2019 | Q1 | -- | $198.4M | $0.05 | -- | -- |
| 12/31/2018 | Q4 | -- | $179.4M | $0.20 | -- | -- |
| 09/30/2018 | Q3 | -- | $159.6M | $0.15 | -- | -- |
| 06/30/2018 | Q2 | -- | $172.4M | $0.32 | -- | -- |
| 03/31/2018 | Q1 | -- | $157M | $0.95 | -- | -- |
| 12/31/2017 | Q4 | -- | $142.6M | $0.23 | -- | -- |
| 09/30/2017 | Q3 | -- | $181.9M | $0.25 | -- | -- |
| 06/30/2017 | Q2 | -- | $181.7M | $0.25 | -- | -- |
| 03/31/2017 | Q1 | -- | $169.3M | $0.20 | -- | -- |
| 12/31/2016 | Q4 | -- | $160M | $0.20 | -- | -- |
| 09/30/2016 | Q3 | -- | $157.6M | $0.15 | -- | -- |
| 06/30/2016 | Q2 | -- | $147.5M | $0.12 | -- | -- |
| 03/31/2016 | Q1 | -- | $135.3M | -$1.22 | -- | -- |
| 12/31/2015 | Q4 | -- | $120M | -$0.07 | -- | -- |
Azenta, Inc. reported $159.2M worth of top line sales in its most recent quarter.
Azenta, Inc. announced earnings per share of $1.11 which represents a beat of analyst forecast a $0.20 per share.
Azenta, Inc. reported $72.3M that represents $1.57 per share over the last quarter.
Azenta, Inc.'s earnings are forecast to decrease from -$1.22 per share to $0.51 per share next year representing a decrease of -99.29%.
Azenta, Inc.'s next earnings date is February 4, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.